October 16-18, 2012
Speaker:
Topic: Oral anti-CD3 MAb immunotherapy - clinical proof of principle
July 16-19, 2012
Speaker:
Topic: Novel monoclonal antibody for treating Alzheimer’s disease.
June 05-07, 2012
Speaker:
Topic: Oral anti-CD3 MAb immunization - clinical proof of principle; and Novel antibody immunotherapy for treating Alzheimer's disease.
May 21-23, 2012
Speaker:
Topic: New immunotherapy for Alzheimer's disease
January 30-February 01, 2012
Speaker:
Topic:
November 30-December 01, 2011
Speaker:
Topic: Oral anti-CD3 immunotherapy - Proof of concept in man
June 20-24, 2011
Speaker:
Topic: Uncovering the potential of Oral anti-CD3 antibody “vaccination” for autoimmune and inflammatory diseases and of novel universal Pneumococcal vaccine.
May 23-25, 2011
Speaker:
Topic: Oral anti-CD3 antibody immunotherapy – Proof of concept in man
May 11-13, 2011
Speaker:
Topic: Oral anti-CD3 antibody immunotherapy – Proof of concept in man
April 11-14, 2011
Speaker:
Topic: Oral anti-CD3 antibody vaccination for autoimmune and inflammatory diseases - results of Phase 2a clinical trial for subjects with NASH
June 21-23, 2010
Speaker:
Topic: Using an alternative animal model for toxicology of a novel Alzheimer’s disease immunotherapeutic
June 14-16, 2010
Speaker:
Topic: Developing new vaccines
November 16-19, 2009
Speaker:
Topic: Vaccine immunotherapy for Alzheimer’s Disease using monoclonal antibodies to the β-secretase cleavage site of Amyloid Precursor Protein
April 22-26, 2009
Speaker:
Topic: New frontiers in vaccine development
December 02-03, 2008
Speaker:
Topic: Development of a novel adjuvanted flu vaccine
July 17-18, 2008
Speaker:
Topic: New Opportunities for Vaccines
June 17-20, 2008
Speaker:
Topic: New Opportunities for Vaccines
June 02-05, 2008
Speaker:
Topic: Case study: Development of influenza vaccine: from bench to clinic